Enable Injections Inc. said today that it closed a $30 million Series A round to bring its large-volume injector to market. The Cincinnati, Ohio-based company’s Enable Injector adheres to a patient’s body and delivers biologic doses as large as 50 milliliters. It can be used at work or at home, providing an alternative to costly […]
Funding Roundup
QuiO raises $1m for smart injection device
QuiO said last week that it closed a $1.05 million seed round led by undisclosed investors to finish developing its smart injection device, prep for pilot studies and an FDA 510(k) submission. The New York-based company is developing a smart injection device and software to monitor patient adherence to clinical trial and daily regimens. Average […]
Sancilio withdraws $86m IPO for lipid-based drug delivery
Sancilio Pharmaceuticals last week withdrew its plans for an initial public offering it hoped would bring in $86 million for its Advanced Lipid Technology drug delivery platform. The Florida-based company registered the IPO in August 2015, but today requested that the SEC consent to its withdrawal, without giving a specific reason. The company’s drug delivery […]
Credence MedSystems raises $15m for safe-syringe drug delivery
Credence MedSystems announced today that it raised $15 million in a Series A round to fund continued development and commercialization of its injectable drug-delivery device. The company’s flagship device is the Credence Companion safety syringe, a pre-fillable device sold to drug manufacturers for use with injectable medications. The user injects their medication, gets a cue […]
Chrono Therapeutics closes $48m Series B for smart nicotine patch
Hayward, Calif.-based startup Chrono Therapeutics reportedly raised $47.6m in a Series B round, led by Kaiser Permanente Ventures. The money, Chrono CEO Alan Levy told Forbes, is to fund clinical trials of a transdermal smoking cessation patch. The company is preparing for a large, Phase II efficacy study of the technology. Unlike normal nicotine patches, Chrono said […]
